Vial size, weekly dose, coverage, price
Those are the four columns, and they are the four things a reader actually needs. Six tirzepatide rows and five semaglutide rows, each saying what strength the vial is, what weekly dose it supports, and how many weeks it lasts.
The coverage periods are not months. They are eight, nine-to-twelve, ten and twelve weeks depending on the row, and the semaglutide ladder drops from ten weeks to eight at its higher doses — so the cost per week rises faster than the printed price does. One tirzepatide row states its coverage as a range, which makes even a per-week figure ambiguous by a third.
Three pharmacies, with addresses
The partnered-pharmacies page names three by name and gives, for each, a website, a telephone number, a fax number and a street address. One is identified as an outsourcing facility of a stated regulatory class rather than a traditional compounding pharmacy, which is a meaningful distinction and not one most sellers draw.
A separate page names the prescribing clinicians individually, with biographies and the state each serves. Between the two pages, a reader can check both the facility and the prescriber against public registers.
Four states, stated everywhere
The footer of every page says which states it serves, by name. Four of them. That is a small footprint, and stating it in the footer rather than on a buried page means a reader learns it before they invest time in an intake.
What it does not publish is a membership position. The priced page lists what is included — a medical assessment, a personalised plan of care — and never says whether a membership fee applies.
Healthy Resolutions's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $260the seller states this vial covers 10 WEEKS, not a month; the table's own columns are Vial Size, Weekly Dose, Coverage and Price | September 2026source |
| Semaglutide (compounded) | $310stated coverage 10 weeks | September 2026source |
| Semaglutide (compounded) | $339stated coverage 10 weeks | September 2026source |
| Semaglutide (compounded) | $360stated coverage 8 weeks — a shorter period than the cheaper vials above it, so the price per week rises faster than the price per vial | September 2026source |
| Semaglutide (compounded) | $390stated coverage 8 weeks | September 2026source |
| Tirzepatide (compounded) | $385stated coverage 12 weeks, not a month | September 2026source |
| Tirzepatide (compounded) | $410stated coverage 12 weeks | September 2026source |
| Tirzepatide (compounded) | $450⛔ stated coverage "9 to 12 weeks" — the seller itself gives a range, so even a per-week conversion is ambiguous by a third | September 2026source |
| Tirzepatide (compounded) | $495stated coverage 12 weeks | September 2026source |
| Tirzepatide (compounded) | $545stated coverage 12 weeks | September 2026source |
| Tirzepatide (compounded) | $595stated coverage 12 weeks; the top of the published ladder | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See Healthy Resolutions's current price →Good fit if
- Readers in Connecticut, Massachusetts, New York or Tennessee.
- Buyers who will not order without knowing which facility compounds the medication.
- People who want the prescriber named and their state stated.
- Anyone who wants to know how many weeks a purchase actually covers.
Look elsewhere if
- Anyone outside the four states named in its footer.
- Readers who want a monthly figure without doing a conversion.
- Buyers who need the membership question answered.
- People at higher semaglutide doses, where the same ladder covers fewer weeks per purchase.
How this review was verified
- Re-read the priced weight-loss page, the partnered-pharmacies page, the providers page and the states-we-cover page on 7 September 2026, comparing requested to effective URLs and running a nonsense path against the host in the same run, which returned a 404.
- Recorded every row of both ladders with its stated coverage period, and stored all of them as non-monthly so no page can print a per-month suffix beside a vial price.
- Recorded the three pharmacy names, their contact details and the regulatory class stated for one of them, rather than recording that pharmacies are named.
- Read the service-area statement off the footer that renders on every page, and matched it against the four state names rather than a heading.
- Screened the brand against FDA's live warning-letter datatable with a positive control and a nonsense negative control in the same invocation; the screen returned zero matches, so the absence is measured rather than assumed.